Kylie A. Browne

3.8k total citations
37 papers, 2.9k citations indexed

About

Kylie A. Browne is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Kylie A. Browne has authored 37 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 16 papers in Molecular Biology and 13 papers in Hematology. Recurrent topics in Kylie A. Browne's work include Autoimmune and Inflammatory Disorders Research (13 papers), Cell death mechanisms and regulation (12 papers) and Immune Cell Function and Interaction (10 papers). Kylie A. Browne is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (13 papers), Cell death mechanisms and regulation (12 papers) and Immune Cell Function and Interaction (10 papers). Kylie A. Browne collaborates with scholars based in Australia, New Zealand and Finland. Kylie A. Browne's co-authors include Joseph A. Trapani, Vivien R. Sutton, Mark J. Smyth, David A. Jans, Annette Ciccone, Joanne E. Davis, Ricky W. Johnstone, Ilia Voskoboinik, Marc Feldmann and Brian M. J. Foxwell and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kylie A. Browne

37 papers receiving 2.9k citations

Peers

Kylie A. Browne
Zvi Fishelson Israel
Arnold Pizzey United Kingdom
Takashi Imai Japan
Mathias G. Lichtenheld United States
Takeshi Kondo Japan
Nobuo Sakaguchi Japan
Vivien R. Sutton Australia
D W Lancki United States
Katsuyuki Yui Japan
Zoe Waibler Germany
Zvi Fishelson Israel
Kylie A. Browne
Citations per year, relative to Kylie A. Browne Kylie A. Browne (= 1×) peers Zvi Fishelson

Countries citing papers authored by Kylie A. Browne

Since Specialization
Citations

This map shows the geographic impact of Kylie A. Browne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kylie A. Browne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kylie A. Browne more than expected).

Fields of papers citing papers by Kylie A. Browne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kylie A. Browne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kylie A. Browne. The network helps show where Kylie A. Browne may publish in the future.

Co-authorship network of co-authors of Kylie A. Browne

This figure shows the co-authorship network connecting the top 25 collaborators of Kylie A. Browne. A scholar is included among the top collaborators of Kylie A. Browne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kylie A. Browne. Kylie A. Browne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spicer, Julie A., P. D. T. O’Connor, Jiney Jose, et al.. (2017). Substituted arylsulphonamides as inhibitors of perforin-mediated lysis. European Journal of Medicinal Chemistry. 137. 139–155. 8 indexed citations
2.
Spicer, Julie A., P. D. T. O’Connor, Jiney Jose, et al.. (2016). Benzenesulphonamide inhibitors of the cytolytic protein perforin. Bioorganic & Medicinal Chemistry Letters. 27(4). 1050–1054. 14 indexed citations
3.
Huttunen, Kristiina M., William A. Denny, Jagdish K. Jaiswal, et al.. (2015). Diarylthiophenes as inhibitors of the pore-forming protein perforin. Bioorganic & Medicinal Chemistry Letters. 26(2). 355–360. 17 indexed citations
4.
Lyons, Dani M., Kristiina M. Huttunen, Kylie A. Browne, et al.. (2011). Inhibition of the cellular function of perforin by 1-amino-2,4-dicyanopyrido[1,2-a]benzimidazoles. Bioorganic & Medicinal Chemistry. 19(13). 4091–4100. 25 indexed citations
5.
Spicer, Julie A., Kristiina M. Huttunen, William A. Denny, et al.. (2011). Inhibition of the pore-forming protein perforin by a series of aryl-substituted isobenzofuran-1(3H)-ones. Bioorganic & Medicinal Chemistry. 20(3). 1319–1336. 15 indexed citations
6.
Law, Ruby H. P., Natalya Lukoyanova, Ilia Voskoboinik, et al.. (2010). The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature. 468(7322). 447–451. 315 indexed citations
7.
Baran, Katherine, Michelle A. Dunstone, Jenny Chia, et al.. (2009). The Molecular Basis for Perforin Oligomerization and Transmembrane Pore Assembly. Immunity. 30(5). 684–695. 102 indexed citations
8.
Sutton, Vivien R., Nigel J. Waterhouse, Katherine Baran, et al.. (2008). Measuring cell death mediated by cytotoxic lymphocytes or their granule effector molecules. Methods. 44(3). 241–249. 19 indexed citations
9.
Voskoboinik, Ilia, Jamie I. Fletcher, Annette Ciccone, et al.. (2004). Calcium-dependent Plasma Membrane Binding and Cell Lysis by Perforin Are Mediated through Its C2 Domain. Journal of Biological Chemistry. 280(9). 8426–8434. 118 indexed citations
10.
Kelly, Janice M., Nigel J. Waterhouse, Erika Cretney, et al.. (2004). Granzyme M Mediates a Novel Form of Perforin-dependent Cell Death. Journal of Biological Chemistry. 279(21). 22236–22242. 105 indexed citations
11.
Voskoboinik, Ilia, Kylie A. Browne, Erika Cretney, et al.. (2004). The Functional Basis for Hemophagocytic Lymphohistiocytosis in a Patient with Co-inherited Missense Mutations in the Perforin (PFN1) Gene. The Journal of Experimental Medicine. 200(6). 811–816. 62 indexed citations
12.
Waterhouse, Nigel J., Karin Sedelies, Kylie A. Browne, et al.. (2004). A Central Role for Bid in Granzyme B-induced Apoptosis. Journal of Biological Chemistry. 280(6). 4476–4482. 106 indexed citations
13.
Davis, Joanne E., Vivien R. Sutton, Kylie A. Browne, & Joseph A. Trapani. (2003). Purification of natural killer cell cytotoxic granules for assaying target cell apoptosis. Journal of Immunological Methods. 276(1-2). 59–68. 18 indexed citations
14.
Browne, Kylie A., Ricky W. Johnstone, David A. Jans, & Joseph A. Trapani. (2000). Filamin (280-kDa Actin-binding Protein) Is a Caspase Substrate and Is Also Cleaved Directly by the Cytotoxic T Lymphocyte Protease Granzyme B during Apoptosis. Journal of Biological Chemistry. 275(50). 39262–39266. 79 indexed citations
15.
Quattrocchi, Emilia, Marita J. Walmsley, Kylie A. Browne, et al.. (1999). Paradoxical Effects of Adenovirus-Mediated Blockade of TNF Activity in Murine Collagen-Induced Arthritis. The Journal of Immunology. 163(2). 1000–1009. 64 indexed citations
16.
Croxford, J. Ludovic, J.K. O'Neill, Robin R. Ali, et al.. (1998). Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis. European Journal of Immunology. 28(12). 3904–3916. 40 indexed citations
17.
Trapani, Joseph A., David A. Jans, Patricia Jans, et al.. (1998). Efficient Nuclear Targeting of Granzyme B and the Nuclear Consequences of Apoptosis Induced by Granzyme B and Perforin Are Caspase-dependent, but Cell Death Is Caspase-independent. Journal of Biological Chemistry. 273(43). 27934–27938. 137 indexed citations
18.
Trapani, Joseph A., Kylie A. Browne, Mark J. Smyth, & David A. Jans. (1996). Localization of Granzyme B in the Nucleus. Journal of Biological Chemistry. 271(8). 4127–4133. 91 indexed citations
19.
20.
Smyth, Mark J., et al.. (1994). HYPOTHESIS: CYTOTOXIC LYMPHOCYTE GRANULE SERINE PROTEASES ACTIVATE TARGET CELL ENDONUCLEASES TO TRIGGER APOPTOSIS. Clinical and Experimental Pharmacology and Physiology. 21(1). 67–70. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zvi Fishelson Breakdown of academic impact, for papers by Arnold Pizzey Breakdown of academic impact, for papers by Takashi Imai Breakdown of academic impact, for papers by Mathias G. Lichtenheld Breakdown of academic impact, for papers by Takeshi Kondo Breakdown of academic impact, for papers by Nobuo Sakaguchi Breakdown of academic impact, for papers by Vivien R. Sutton Breakdown of academic impact, for papers by D W Lancki Breakdown of academic impact, for papers by Katsuyuki Yui Breakdown of academic impact, for papers by Zoe Waibler
Rankless by CCL
2026